<DOC>
	<DOCNO>NCT01302743</DOCNO>
	<brief_summary>The purpose study ass whether Cinnamon bark water-soluble cinnamon effective nutraceutical initial treatment diabetes compare standard therapy Metformin .</brief_summary>
	<brief_title>Cinnamon Bark , Water-Soluble Cinnamon Extract , Metformin Treatment Type 2 DM .</brief_title>
	<detailed_description>We study whether cinnamon bark water-soluble cinnamon could effective nutraceutical initial treatment diabetes compare standard therapy metformin 1000 mg ( extended-release ) . This study enroll 309 subject type 2 diabetic ( use American Diabetes Association criterion ) hypoglycemic medication . Subjects randomize one three group , group 1 receive oral extended-release Metformin 1000mg , group 2 receive Cinnamon Bark 1000mg , group 3 receive cinnulin PF 500mg . Subjects instruct take study pill day 90 days.After 90 day treatment , subject hemoglobin A1C , lipid panel , height , weight , blood pressure waist circumference measure . Analysis describe use intention-to-treat principle miss data use ( use carry-forward method impute miss data ) . Subjects bring remain medication determine adherence rate study protocol .</detailed_description>
	<mesh_term>Metformin</mesh_term>
	<criteria>THIS STUDY IS BEING CONDUCTED AT A MILITARY INSTALLATION . YOU MUST HAVE MILITARY INSURANCE IN ORDER TO PARTICIPATE IN THIS STUDY . Inclusion : Patients 18 year old . Diagnosed type 2 diabetes mellitus within past 30 day diagnose begin treatment . Exclusion : Subjects &lt; 18 yrs age . Pregnant breastfeeding . Allergic cinnamon . Allergic metformin . Patients take metformin exclude participating , unless agree wash two week prior enter study . Patients take Cinnamon dietary supplement exclude participating , unless agree wash two week prior enter study . Patients take following : Daily oral steroid Warfarin Hypoglycemic medication Weight loss medication Digoxin , lithium , phenytoin , &amp; theophylline ( due narrow therapeutic index ) Serum creatinine &gt; 1.5 ( standard care would measure PCM upon diagnosis type 2 diabetes mellitus ) Initial hemoglobin A1C &gt; 9.5 ( standard care would measure PCM upon diagnosis type 2 diabetes mellitus ) . Clinical laboratory evidence liver disease . Clinical laboratory evidence Alcoholism . New York Heart Association ( NYHA ) Class III IV congestive heart failure . Class III : Cardiac disease result marked limitation physical activity less ordinary activity cause fatigue , palpitation , dyspnea , angina . Comfortable rest . Class IV : Cardiac disease result inability carry physical activity without discomfort symptom . Symptoms may present rest . If physical activity undertaken , discomfort symptom increase . Patients know develop study follow upon review medical record : Celiac disease Insulinoma Cushings Disease Hyperthyroidism Acromegaly Phechromocytoma Addison 's Disease Galactosemia Glycogen storage disease Hereditary fructose intolerance</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Diabetes</keyword>
	<keyword>Metformin</keyword>
	<keyword>Cinnamon</keyword>
</DOC>